Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Elevated Blood Pressures in Early Pregnancy
NCT05955040Phase 2Terminated
- Sponsor
- Marshall University
- Start
- Jul 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nifedipine, labetalol in hypertension (HTN), sponsored by Marshall University. Started Jul 2023; status: terminated.
02
Drugs
nifedipinelabetalol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05955040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05955040.